SEC Form 4 research
| Issuer | Axsome Therapeutics, Inc. |
|---|---|
| Tickers | AXSM |
| Reporting owners | 15 |
| Officers and directors | 9 |
| Last public filing | 2026-09-04 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-09-03 | 2026-09-03 | Jacobson Mark L. | S | 10,000 | $208.65 | Not reported |
| 2026-08-07 | 2026-08-06 | TABUTEAU HERRIOT | S | 4,660 | $213.95 | Not reported |
| 2026-08-07 | 2026-08-05 | TABUTEAU HERRIOT | S | 45,004 | $212.01 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.